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cantly lower mean Total scores than controls (54.7 vs. 99.2; P0.0001), Sleep/energy
scores (55.9 vs. 100.0; P0.0001), and Bother/concern scores (54.0 vs. 98.3; P0.0001),
indicating greater health-related quality of life impairment because of nighttime
urination. CONCLUSIONS: The Stanford Sleepiness Scale, Epworth Sleepiness
Scale, and N-QoL all effectively discriminate between participants with OAB symp-
toms and those without OAB symptoms.
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A SYSTEMATIC REVIEW OF ECONOMIC EVALUATIONS CONDUCTED FOR
ASSESSMENT OF GENETIC TESTING TECHNOLOGIES
Assasi N, Schwartz L, Tarride JE, Goeree R, Xie F
McMaster University, Hamilton, ON, Canada
OBJECTIVES: The conventional economic evaluations (EE) methods may be chal-
lenging within the context of genetic testing technologies (GTTs), because: the
main outcome a GTT is information, benefits may occur many years after taking
the test, non-medical harms might be associated with GTTs, and GTTs may also
provide information about the genetic status of the family members of affected
individuals. This study was performed to systematically review the methods used
in EEs included in Health Technology Assessments (HTAs) of GTTs. METHODS: A
systematic search of literature was undertaken to identify HTA reports on GTTs
that included EEs in addition to clinical effectiveness results. Studies were re-
viewed in terms of methods (e.g. type of EE, analytic perspective, cost-effectiveness
analysis), and quality (using QHES instrument).RESULTS:Of 342 identified citations,
13 HTAs consisting of 10 model-based and 3 trial-based EEs were included. More than
50% of the included studies had moderate to low quality scores mainly due to not
reporting information on basic elements of a standard EE and inadequate manage-
ment of uncertainty. Cost-effectiveness analysis (CEA) accounted for 62% of included
studies. 65% of the studies adopted a third party payer perspective, and 60% used a
lifelong time horizon. 75% of CEAs reported intermediate outcomes (e.g. cases-de-
tected). The majority of studies exclusively included technical costs of testing (100%)
and therapeutic or preventive interventions (62%). The most frequent variables tested
in univariate sensitivity analysis included costs (62%), effects (46%) and transition
probabilities (54%). Probabilistic sensitivity analysis was conducted in 31% of studies.
CONCLUSIONS: We found several methodological challenges in the reviewed EEs,
including: identification of a proper analytical perspective, inclusion of wider range
of outcomes and costs, allowing for long-term psychological, ethical and social
impacts of genetic tests, and sufficient management of uncertainty. These issues
should be carefully considered in future EEs of GTTs.
Surgery – Clinical Outcomes Studies
PSU1
SUPRAPUBIC TUBE PLACEMENT RELATED BOWEL INJURY: PROPOSED
GUIDELINES FOR OPEN PLACEMENT
Ellsworth P1, Tompkins A1, Lasser M2
1Brown University, Providence, RI, USA, 2Brown University, providence, RI, USA
OBJECTIVES: Suprapubic catheterization (SPT) is a common urologic procedure
performed on an elective and urgent basis. Percutaneous approaches have devel-
oped in an effort to circumvent the need for general/spinal anesthesia, but are not
without risk. Rates of SPT-related bowel injury range from 0.3% to 2.7%. We expe-
rienced 4 cases and reviewed the literature to determine identifiable risk factors for
bowel injury.METHODS:A literature review was performed of all English language
articles listed in PubMed and articles reporting percutaneous SPT placement re-
lated bowel injury were selected. Included in our review are 4 cases in our institu-
tion. Data from articles and our cases was extracted to determine the technique of
SPT placement utilized, underlying risk factors, and nature of bowel injury.
RESULTS: Nineteen papers reported 22 cases of bowel injury as a result of percu-
taneous SPT placement, 2 of which were excluded for insufficient data. Addition-
ally, the 4 cases at our institution were included in the analysis. Small capacity or
thick-walled neurogenic bladders (4/24, 17%), prior abdominal surgery (13/24, 54%),
and pelvic radiation (5/24, 21%) were associated with bowel injury during SPT
placement. Diagnosis of bowel injury was based on history, physical examination
and imaging modalities. Bowel injury had a bimodal presentation, at initial place-
ment (14/24, 58%) and at initial SPT change (10/24, 42%). CONCLUSIONS: Based on
this review we advocate consideration of open SPT placement in patients with
small capacity or thick-walled neurogenic bladders, those in whom the bladder
cannot be distended adequately, prior abdominal/pelvic surgery or radiation, as-
cites. If percutaneous SPT is planned, Trendelenburg positioning and use of ultra-
sound and/or fluoroscopy at time of SPT placement is supported by the literature.
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COMPARISON OF SEIZURE AND HYDROCEPHALUS AND OTHER CLINICAL
CONDITIONS BEFORE AND AFTER SUBEPENDYMAL GIANT CELL
ASTROCYTOMA SURGERY IN PATIENTS WITH TUBEROUS SCLEROSIS COMPLEX
Sun P1, Liu Z2, Rogerio J2, Guo A2, Garay C2, Kohrman M3
1Kailo Research Group, Fishers, IN, USA, 2Novartis Pharmaceuticals Corporation, East Hanover,
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OBJECTIVES: To compare the prevalence rates of seizure, hydrocephalus and other
clinical conditions before and after a surgical removal of subependymal giant cell
astrocytoma (SEGA) in patients with tuberous sclerosis complex (TSC). METHODS:
A pre-post comparative longitudinal cohort study was conducted based on 3 large
US national healthcare claims databases (2000-2009). TSC patients with a first ob-
served SEGA surgery at age 35 or younger and with continuous health insurance
coverage 1 year before and 1 year after the surgery were selected. The prevalence
rates of seizure, hydrocephalus, and other TSC related clinical conditions, such as
vision disorders, coma, speechlessness, headache, stroke or hemiparesis, cognitive
difficulties, muscle weakness, papillodema, balance disorders, loss of sensation,
nausea and vomiting, depression, anxiety, attention deficit disorders, autism, and
sleep disorders, were estimated and compared between a period of the last 6 pre-
operative months and the first two postoperative periods (the 2nd to 6th postoper-
ative months; 7th to 12th postoperative months). Repeated measures analysis with
bootstrapping re-sampling approach was used for the cross-period comparisons.
RESULTS: The mean age of the select patients (N47) was 11.6 year at their first
observed SEGA surgery; the majority of the patients were male (66%). Statistically
significant postoperative increases in the prevalence rates of seizure (23 26%,
p0.05), hydrocephalus (2126%, p0.05), headache (1719%, p0.05), stroke and
hemiparesis (69%, p0.05), and autism (9%, p0.05) were observed.
CONCLUSIONS: This real-world claim data showed an increase in the risk of some
clinical conditions including seizure and hydrocephalus after a SEGA surgery in
patients with TSC. Further research to explore any possible causal relationship
between these risk increases and SEGA surgery through prospective studies or
registries is needed.
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PREVALENCE RATES OF SURGICAL COMPLICATIONS AMONG TUBEROUS
SCLEROSIS COMPLEX PATIENTS WITH SURGICAL REMOVAL OF
SUBEPENDYMAL GIANT CELL ASTROCYTOMA: A REAL-WORLD NATIONAL
RETROSPECTIVE COHORT STUDY
Sun P1, Liu Z2, Rogerio J2, Guo A2, Garay C2, Kohrman M3
1Kailo Research Group, Fishers, IN, USA, 2Novartis Pharmaceuticals Corporation, East Hanover,
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OBJECTIVES: To examine the prevalence rates of surgical complications among
tuberous sclerosis complex (TSC) patients with surgical removal of subpendymal
giant cell astrocytoma (SEGA). METHODS: Based on 3 US national health care
claims databases (20002009), a retrospective cohort study was conducted in TSC
patients who had a SEGA surgery at age 35 or younger, and were under continuous
health insurance coverage 1 year before and 1 year after the surgery. A SEGA sur-
gery was identified by a healthcare claim that simultaneously had a TSC diagnosis
code, a benign brain tumor diagnosis code and a procedure code of removing a
benign tumor from cerebral ventricle system. The surgical complications exam-
ined in the study included surgical procedure complications, nervous system com-
plications, surgical misadventures, postoperative infection, subdural empyemas,
and epidural abscess. The prevalence rates of these conditions were estimated for
the first postoperative year. RESULTS: Approximately 47 TSC patients had at least
one SEGA surgery. The mean age of patients at their 1st observed SEGA surgery was
11.6 years. The majority of patients (66%) were male. The prevalence rates of sur-
gical complications in the 1st postoperative year were 34% for surgical procedure
complications, 17% for subdural empyemas, 12.8% for nervous system complica-
tions, 6% for postoperative infection, 2% for epidural abscess, and 0% for surgical
misadventures respectively. CONCLUSIONS: In this real-world claim database
analysis, we observed that a portion of TSC patients experienced surgical compli-
cations within first year after their SEGA surgeries. Further research is needed to
better understand the causes of this surgical outcome.
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POSTOPERATIVE PREVALENCE RATE OF SUBEPENDYMAL GIANT CELL
ASTROCYTOMA (SEGA) DIAGNOSIS AND REPEATED SEGA SURGERY IN
PATIENTS WITH TUBEROUS SCLEROSIS COMPLEX: A REAL-WORLD NATIONAL
RETROSPECTIVE COHORT STUDY
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OBJECTIVES: To examine the postoperative prevalence of subependymal giant cell
astrocytoma (SEGA) diagnosis and repeated SEGA surgeries among patients with
tuberous sclerosis complex (TSC) who had an initial SEGA surgery. METHODS:
Based on three US national health claims databases (20002009), we conducted a
retrospective cohort study with TSC patients who had a first observed SEGA sur-
gery at age 35 or younger and were under continuous health insurance coverage 1
year before and 1 year after their 1st SEGA surgery. A SEGA surgery was defined as
having 1) a TSC diagnosis code, 2) a benign brain tumor diagnosis code, and 3) a
procedure code for removing a benign tumor from cerebral ventricle system. A
SEGA diagnosis is defined as 1) and 2). The prevalence rates of postoperative SEGA
diagnosis and repeated SEGA surgery were estimated for a period from the 3rd
through 6th postoperative month and a period from the 7th through 12th postoper-
ative month respectively. RESULTS: The select patients (N47) had mean age of
11.6 years (at the 1st SEGA surgery) with 66% males. After the 1st observed SEGA
surgery, postoperative prevalence rates of SEGA diagnosis was 34% in the period
from the 3rd to 6th postoperative month and 26% in the period from the 7th to 12th
postoperative month. About 49% patients had a repeated SEGA surgery in their 1st
postoperative year. CONCLUSIONS: In the real-world setting, TSC patients with
SEGA surgery may experience repeated SEGA surgeries or/and still have SEGA di-
agnoses within the first postoperative year. Further research on the effectiveness
of SEGA surgery via prospective studies or registries is needed to improve care in
TSC patients with SEGA.
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RISK OF ARTHRITIS AS A PREDICTOR FOR THE MISDIAGNOSIS OF
CHONDROLYSIS: AN INTERNATIONAL ANALYSIS OF CLINICAL OUTCOMES
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1Advance Health Solutions, La Jolla, CA, USA, 2Naval Medical Center San Diego, San Diego, CA,
USA, 3Marin Orthopedics and Sports Medicine, Novato, CA, USA, 4Advance Health Solutions,
LLC, La Jolla, CA, USA
A260 V A L U E I N H E A L T H 1 4 ( 2 0 1 1 ) A 2 3 3 - A 5 1 0
OBJECTIVES: Chondrolysis is defined as the rapid and diffuse loss of articular car-
tilage, typically within 12 months after surgery. Although described in nearly all
diarthroidial joints, recent studies have shown that chondrolysis has been misdi-
agnosed in numerous case reports. This study aimed to determine contributing
factors associated with the misdiagnosis of chondrolysis to help improve accurate
diagnostication and clinical decision making. METHODS: A systematic literature
review identified 128 publications on 783 joints (626 hips, 128 shoulders, and 29
knees) diagnosed as chondrolysis. Among these, 72 joints (48% knees, 9% shoul-
ders, and 7% hips) were determined to be misdiagnosed by consensus across five
orthopaedic surgeons. A broad range of data was examined in relation to misdiag-
nosis. For all cases, the presenting diagnosis and surgical procedure(s) as well as
other potential contributors including chemical, thermal, and mechanical factors
were examined to estimate the differential risk of rapidly developing osteoarthritis
which was categorized as low, moderate, or high. Descriptive statistics, bivariate
comparisons, and multivariate regression analyses were performed, with p0.05
denoting significance. RESULTS: Misdiagnosis of chondrolysis was neither associ-
ated with arthroscopic procedures nor chemical, thermal, or mechanical factors
during surgery. Among correctly diagnosed cases, the risk of developing rapid
osteoarthritis was considered low among 94.4% (671/711), moderate among 1.0%
(7/711), and high among 4.6% (33/711). In contrast, among misdiagnosed cases,
13.9% (10/72) of presenting diagnoses were considered low risk for osteoarthritis,
19.4% (14/72) moderate, and 66.7% (48/72) high. After adjusting for potential con-
founders, the single most significant predictor associated with misdiagnosis of
chondrolysis was a presenting medical condition that increased the risk of devel-
oping rapid osteoarthritis (p0.01). CONCLUSIONS: Misdiagnosis of chondrolysis
appears to be strongly correlated with the risk of rapidly developing osteoarthritis,
a pathology that is characterized by chronic and focal degeneration of cartilage
rather than rapid and diffuse cartilage loss that signify chondrolysis.
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LONG TERM EFFECTIVENESS OF LIMBAL RELAXING INCISION (LRI) DURING
CATARACT SURGERY TO CORRECT ASTIGMATISM
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OBJECTIVES:Correction of astigmatism during cataract surgery is important to free
the patient from distance vision spectacles. Several techniques are available: Laser,
Toric intraocular lenses and LRI. This abstract reports on the long term effective-
ness of LRI. METHODS: The charts of all patients having had LRI during cataract
surgery done by LG were extracted. The LRI consisted of a 6 mm length contra-
lateral limbal incision with a 600m depth calibrated lancet. The main outcome
was objective keratometry. Vector analysis was conducted according to Alpins and
Goggin. Success was defined as at least one diopter cylinder reduction in its axis
(/ 22.5°), independent of the pre-operative astigmatism (emmetropia was not
the objective). Keratometries performed before 3 months were not taken into ac-
count in the survival analyses (Kaplan-Meyer). RESULTS: A total of 129 eyes were
included in the analysis. Patients mean age was 68.3 and the sex ratio was 47 males:
53 females. Average follow-up was 2.0 years. On average, the cylinder was 1.8D (1.1)
before surgery and 1.4D (0.9) at one year. No major axis shift was observed on
average (from -1.6° at week 4 to 2.9° after 2 years) while its standard deviation was
high (from 73° at week 4 to 62° after 2 years). Success rates were 78% at week 50, 48%
at week 100 and 23% at week 250. CONCLUSIONS: A 6 mm length contra-lateral
limbal incision does not allow a 1D cylinder correction. The predictability of cor-
recting astigmatism along the cylinder axis is low. Consequently, the success rate
is low at week 50 and declining over the long term. The probability to be free of
distance vision glasses and to realize the associated savings is uncertain with LRI.
Lastly, interpreting effectiveness results of LRI based on vector analysis parameter
averages is misleading.
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IMPLICATIONS OF ALLOARTHROPLASTIC INFECTIONS IN HIP AND KNEE
SURGERY
Letsch R1, Juelicher P2, Letsch J3, Graf J3
1Vivantes Humboldt Klinikum, Berlin, Germany, 2Johnson & Johnson Medical, Norderstedt,
Germany, 3Charité, Berlin, Germany
OBJECTIVES: Evaluation of diagnostic, epidemiological, microbiological, surgical,
and economic parameters of periprosthetic hip and knee infections. METHODS:
Data of a large Berlin hospital group (5000 beds) were analysed over 3 years for the
above mentioned criteria. RESULTS: A total of 7524 arthroplasties from January 1,
2007 - December 2009 were performed because of femoral neck fractures and ar-
thritis of hip/knee; 18.1% of them were revisions, 319 of these (259 patients) due to
infection. All received major revision surgery; i.e. 208 patients underwent 1 revi-
sion, 43 patients 2, 7 patients 3, and 1 patient 4. Pathogen organisms were 57 x
coag-neg. Staphylococci, 54 x Staph. aureus, 21 x Enterococci, and 19 x Streptococci,
with a wide variety of further bacteria in fewer numbers. 72 SSI-infections were
multibacterial. MRSA was encountered 8 x. In 99 specimen bacteriology was neg-
ative. Most revisions were performed as two-stage procedures. Pre-op joint punc-
ture was carried out 92 x, with a positive result in 59 cases. Antibiotic treatment
was more effective, when pre-op bacterial diagnosis permitted a targeted drug
application. Age and ASA classification played no role in the prevalence of
periprosthetic infections. There were differences between hospitals, septic surgery
ranging from 4.5% up to 40.9% of all operative revisions (specialized departments).
Length and frequency of hospital stay were extended grossly, when infection oc-
curred, as well as the number of diagnostic and therapeutic measures. Besides the
individual disaster this resulted in a large increase in total cost for septic revision
surgery. CONCLUSIONS: Periprosthetic infections represent a catastrophe for the
patient, a burden for the therapeutic team and an economical hazard for society.
Methods to avoid this complication are high hygienic standards, early clinical de-
tection of infection, meticulous, repeated bacterial diagnostics, radical surgery,
and specific antibiotic treatment. The present study confirms these recommenda-
tions by analysis of 300 surgical revisions of alloarthroplastic infections.
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RISKS AND BENEFITS OF ACRYSOF® CACHET™ IMPLANTATION IN HIGH
MYOPIA (>-6 DIOPTRE): A SYSTEMATIC LITERATURE REVIEW
Siddiqui MK1, Mann K1, Vonmaltzahn R2, Ternouth AM2, Verboven Y3, Berdeaux G4
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OBJECTIVES: To assess risks and benefits associated with AcrySof® Cachet
™
, other
marketed phakic intraocular lenses (PIOLs) in Europe, and laser refractive surgery
(RS) in patients with high myopia (HM). METHODS: MEDLINE, Embase, and Co-
chrane databases were searched for randomised controlled trials and observa-
tional studies conducted in HM patients. Two reviewers undertook data extraction
followed by reconciliation of included studies. Meta-analysis was performed to
combine comparative data; weighted means were calculated for single arm stud-
ies. The quality of single arm studies was assessed using Downs and Black checklist
(score 12: excellent quality). RESULTS: Of 1853 abstracts screened, 51 studies (23
comparative, 28 single arm studies) were included. Results were statistically sig-
nificant in favour (OR, 95% CI) of PIOLs compared to RS for manifest refractive
spherical equivalent (MRSE) within0.50D (3.42, 1.19–9.90), gain of1 lines of best
spectacles corrected visual acuity (BSCVA) (5.28, 1.26-21.97), and fewer secondary
refractive procedures (0.18, 0.10–0.33). Mean quality index score was 15.04. Base-
line characteristics including myopia severity and anterior chamber depth were
comparable across studies. AcrySof® Cachet™ showed favourable efficacy for un-
corrected distance visual acuity of 20/20 in 46.2% eyes at 3 years post-operative
(Artisan and Visian had 40.8% and 31.0% eyes respectively). Percentage of eyes
needing spectacles (criteria: MRSE not within 0.50D) were 43.45%, 17.19%, and
6.14% for Visian, Artisan, and AcrySof® Cachet™ respectively. For safety, the loss of
1 lines of BSCVA was 0.56% in AcrySof® Cachet™ and 2.25%, 13.16% for Artisan
and Visian respectively. Annualized post 6 month endothelial cell loss (0.41%) was
within the expected rate of natural loss (0.6%0.5%). CONCLUSIONS: PIOLs were
associated with proven favourable efficacy and safety compared to RS. Amongst
PIOLs, within the first 3 years AcrySof® Cachet™ has shown favourable efficacy and
safety. Comparative trials are required to confirm the robustness of results.
PSU9
INCIDENCE OF MAJOR SURGERIES IN PATIENTS WITH METASTATIC
COLORECTAL CANCER
Wang S, Gao SK, Barber B, Wagner V, Zhao Z
Amgen, Inc., Thousand Oaks, CA, USA
OBJECTIVES: Surgical procedures may potentially interfere with anticancer drug
therapy for metastatic colorectal cancer (mCRC). The objective of this study was to
examine the proportion of patients with mCRC who underwent major surgeries.
METHODS: Using a large US medical claims database from a nationally commer-
cially-insured population, patients with diagnosed mCRC between January 2004
and March 2010 were identified. The first metastasis diagnosis date served as the
index date. Patients were followed from the index date to death, disenrollment, or
end of the study period, whichever occurred first. Major surgery was defined ac-
cording to the list of major surgeries developed by the National Committee for
Quality Assurance using Current Procedural Terminology procedure codes. Major
surgeries were examined by anatomic locations: 1) colon or rectum; 2) liver or lung;
and 3) all other anatomic sites. Major surgeries on colon or rectum were assessed
separately, since they likely include a high percentage of interventions to remove
primary tumors. The proportion of major surgeries was descriptively analyzed.
RESULTS: The study sample included 4768 mCRC patients who met the study
inclusion and exclusion criteria between January 2004 and March 2010. Mean age
was 60.0 years old and 45.9% of patients were female. Mean length of follow-up
observation period was over one year (414 days). Overall, 42.3% of patients had at
least one major surgery on anatomic sites other than colon/rectum after mCRC
diagnosis. By anatomic locations, 17.6% of patients had major surgeries on liver or
lung (13.4% on liver and 4.9% on lung); and 32.3% had major surgeries on all other
anatomic sites. Major surgeries on colon or rectum occurred in 35.9% of patients
(32.9% on colon and 4.1% on rectum). CONCLUSIONS: Major surgeries are highly
prevalent in patients with mCRC from this commercially insured population after
mCRC diagnosis. This might have implications for anticancer drug therapy in
mCRC patients.
Surgery – Cost Studies
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ECONOMIC EVALUATION OF MAGNETIC RESONANCE GUIDED FOCUSED
ULTRASOUND IN PATIENTS WITH UTERINE FIBROIDS IN GERMANY
Alvarez-Ossorio L1, Burkowitz J1, Nackunstz I2, Brueggenjuergen B1
1Alpha Care GmbH, Celle, Germany, 2Philips GmbH, Hamburg, Germany
OBJECTIVES: Costs related to Magnetic Resonance Guided Focused Ultrasound
(MR-HIFU) for uterine fibroids have not been compared to alternative treatments
being performed in Germany up to now. Hence, the purpose of this analysis was to
identify the cost-consequences of hysterectomy, myomectomy, uterine artery em-
bolization (UAE) and MR-HIFU in the first year of therapy. In addtition the budget
impact of the MR-HIFU from the perspective of the NHS (direct costs) and social
perspective (indirect costs) should be analysed.METHODS:The cost of leiomyoma-
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